Otsuka America Pharmaceutical
MD · 24 filings, 2025
File · Money Read
What the money shows
Otsuka America Pharmaceutical reported $3.7M in federal lobbying for 2025 across 24 filings. The filings name 6 lobbying firms, led by Government Solutions and THORN RUN Partners. The filing text lists 8 issue areas.
Sources: Senate LDA · FEC
Lobbying spend · 2025
$3.7M
to shape legislation
About the organization
Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha), abbreviated OPC, is a pharmaceutical company headquartered in Chiyoda, Tokyo. The company was established on August 10, 1964. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Veterans · Taxation/Internal Revenue Code · Medicare/Medicaid · Pharmacy · Defense · Budget/Appropriations · Tariff (miscellaneous tariff bills)
2Through these firms · 6
GOVERNMENT SOLUTIONS LLCTHORN RUN PARTNERSOTSUKA AMERICA PHARMACEUTICAL, INC.W STRATEGIES, LLCTODD STRATEGY GROUPDB3, LLC (FKA THE DASCHLE GROUP)
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…